EPHA10, His, Cynomolgus
EPHA10, His, Cynomolgus

The purity of EPHA10, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

EPHA10, His, Cynomolgus

EPHA10, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

EPHA10, His, Cynomolgus

EphA10 (erythropoietin-producing hepatocellular carcinoma receptor A10) is a catalytically defective receptor protein tyrosine kinase in the ephrin receptor family.EphA10 was elevated and higher in tumor tissues than in normal tissues in some cancer types, including pancreatic cancer.EphA10 silencing reduced the proliferation, migration, and adhesion of MIA PaCa-2 and AsPC-1 pancreatic cancer cells. EphA10 plays a pivotal role in the tumorigenesis of pancreatic epithelial cells and is a novel therapeutic target for pancreatic cancer.
Z04781
¥72,752.00

Ask us a question
Product Introduction
Species Cynomolgus
Protein Construction
EPHA10 (Glu34-Ala565)
Accession # XP_045230088.1		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 58.56 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 68-78 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • EPHA10, His, Cynomolgus
    • EPHA10, His, Cynomolgus

    The purity of EPHA10, His, Cynomolgus is greater than 95% as determined by SEC-HPLC.

  • EPHA10, His, Cynomolgus
    • EPHA10, His, Cynomolgus

    EPHA10, His, Cynomolgus on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background EphA10 (erythropoietin-producing hepatocellular carcinoma receptor A10) is a catalytically defective receptor protein tyrosine kinase in the ephrin receptor family.EphA10 was elevated and higher in tumor tissues than in normal tissues in some cancer types, including pancreatic cancer.EphA10 silencing reduced the proliferation, migration, and adhesion of MIA PaCa-2 and AsPC-1 pancreatic cancer cells. EphA10 plays a pivotal role in the tumorigenesis of pancreatic epithelial cells and is a novel therapeutic target for pancreatic cancer.
Synonyms EphA10; FLJ16103; FLJ33655; MGC43817

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.